‘LSD: My Problem Child’ and ‘Insights/Outlooks’ form a fascinating autobiographical account from the founder of LSD about its discovery and the effect it had in the second half of the 21st century. The book, co-published by Beckley Foundation Press and Oxford University Press, is released today to mark the 70th anniversary of Albert Hofmann’s famous bicycle ride while experiencing the world’s first LSD trip.
-
LSD: My Problem Child and Insights/Outlooks
Albert Hofmann's autobiography, providing a fascinating account of the discovery of LSD and the effect it has had on society in the 70 years since the first 'trip'.
-
Cannabis Policy: Moving Beyond Stalemate
Amanda Feilding convened an international team of the world's leading drug policy analysts to write a book analyzing cannabis prohibition policies, which has concluded that criminalization has clearly failed to reduce consumption and has shown there to be no link between prevalence and cannabis policy - be it liberal or draconian.
-
Pharmacology of LSD
This book represents the first ever comprehensive review of the pharmacological effects of LSD. It draws on data from more than 3000 experimental and clinical studies, with more than 1000 referenced.
-
Hoffmann's Elixir: LSD and the New Eleusis
This unique book collects, for the first time, a number of Albert Hofmann's later essays and lectures. Between them they present a comprehensive overview of Hofmann’s relationship to his controversial creation, and reveal his profound mystical outlook, informed both by his own LSD experiences.
-
Moskalenko Monograph
This monograph produced in collaboration with Prof. Yuri Moskalenko, entitled 'Non-Invasive Evaluation of Human Brain Fluid Dynamics and Skull Biomechanics in Relation to Cognitive Functioning', is designed to provide the reader with insights into the importance of Cerebral circulation, Cerbro Spinal Fluid movement and the biomechanical properties of the skull.
-
BF Reports
The Beckley Foundation Drug Policy Programme commissions reports and briefing papers on subjects relevant to national and international drug policy.
